Volume

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy

The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers

The multifaceted role of extracellular vesicles in prostate cancer-a review

The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma

A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia

New mechanisms of multidrug resistance: an introduction to the <i>Cancer Drug Resistance</i> special collection

Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

Emerging resistance <i>vs.</i> losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer

Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/